Biocom is out with a new issue of Deals And Data, a periodic run through the happenings in the biotech world.

The post includes info on Carl Icahn’s battle with Amylin and local folks getting in on the swine flu craze.


Leave a comment

We expect all commenters to be constructive and civil. We reserve the right to delete comments without explanation. You are welcome to flag comments to us. You are welcome to submit an opinion piece for our editors to review.

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.